A dry consumable preparation and related methods are disclosed. The preparation has a bulking agent, and a cannabinoid and/or a cannabinoid extract containing one or more cannabinoids plated onto the bulking agent. The preparation also has an effervescence agent. The effervescence agent has sodium bicarbonate, potassium bicarbonate, and at least one acid, the at least one acid having at least one of citric acid, tartaric acid, or malic acid. The effervescence agent further has a ratio of sodium bicarbonate to potassium bicarbonate to the acid(s) that creates a chemical pH buffering system at a targeted pH range when the dry consumable preparation is added to a targeted amount of water.

The present invention relates to compositions and methods to increase nitric oxide production to: accelerate wound healing, reduce complications from surgery as well as accelerating the recovery period after surgery. The compositions comprise of l-arginine and l-citrulline in ratios and dosages which enable enhanced bioavailability. The method for using the composition for promoting surgery recovery and preparedness includes the step of administering the composition to a patient pre-procedure as well as post-procedure in accordance with a prescribed protocol. The compositions may be customized to include one or more additional agents that are effective for promoting nutritional health and/or treating a particular medical problem.

A dry consumable preparation and related methods are disclosed. The preparation has a bulking agent, and a cannabinoid and/or a cannabinoid extract containing one or more cannabinoids plated onto the bulking agent. The preparation also has an effervescence agent. The effervescence agent has sodium bicarbonate, potassium bicarbonate, and at least one acid, the at least one acid having at least one of citric acid, tartaric acid, or malic acid. The effervescence agent further has a ratio of sodium bicarbonate to potassium bicarbonate to the acid(s) that creates a chemical pH buffering system at a targeted pH range when the dry consumable preparation is added to a targeted amount of water.

The present invention relates to a composition for improving gastrointestinal health comprising bromelain enzyme, short-chain fatty acids, specified amino acids, and vitamin D.

An implantable device for delivery of a macromolecular drug compound is provided. The device comprises a core having an outer surface and a membrane layer positioned adjacent to the outer surface of the core. The core comprises a core polymer matrix within which is dispersed a drug compound having a molecular weight of about 0.5 kDa or more, the polymer matrix containing a hydrophobic polymer. Further, the membrane layer comprises a membrane polymer matrix within which the macromolecular drug compound is optionally dispersed. The membrane polymer matrix contains a hydrophobic polymer in combination with a hydrophilic compound, and the weight ratio of the hydrophobic polymer to the hydrophilic compound within the membrane polymer matrix ranges from about 0.25 to about 200.

Method, apparatus, and computer-readable media to manage undesired sound sources in microphone pickup/focus zones preferably mitigates one or more of the undesired sound source(s) in a space having a plurality of microphones and at least one desired sound source. Preferably, at least one microphone input receives plural microphone input signals from the plurality of microphones in the space. Preferably, the least one processor is coupled to the at least one microphone input and receives the plural microphone input signals. Preferably, the at least one processor determines plural micro-zones in the space. Preferably, the at least one processor determines a threshold sound field level for each micro-zone based on received plural microphone input signals that correspond to the one or more undesired sound source(s). Preferably, the at least one processor recognizes a desired sound source when received plural microphone input signals exceed one or more threshold sound field level.

A method of topically using a combination of Arnica montana extract, bromelain, Calendula extract, daisy flower extract, grape seed extract, copper, and zinc contained in a carrier to promote skin health and healing.

The present invention provides compositions (for example, nutritional compositions or therapeutic compositions) that comprise a probiotic component, colostrum, a protein component, and a detoxification component. The compositions may further comprise a prebiotic component, a tissue constituent component, a symptomatic relief component, a cellular bioenergetics component, a tissue healing component, and/or an enzyme component. Also provided are methods of preventing or treating a disturbance in the integrity of a tissue barrier and/or a mucosal membrane adjacent to or on a tissue of an individual and preventing or treating resulting diseases or conditions by administering such compositions to the individual.

The present embodiments relate to oral compositions comprising geranylgeraniol and to methods of using and of making said compositions. The oral compositions can be used in, for example, an oral rinse, a toothpaste, mouth spray, chewing gum, or impregnated in a disposable toothbrush. The compositions can be applied to the gum, alveolar jaw bone, tooth, tooth tissue, enamel, oral cavity, or tooth socket for many uses including, but not limited to, promoting gum growth and gum support, wound healing, and oral hygiene. Additionally, the oral compositions can be used in a dental product, such as a dental gel, gel sponge, or a bone cement, for other uses, including therapeutic uses, such as, but not limited to preventing or treating a jaw-bone related syndrome or disease, promoting wound healing of gum or enamel, and enhanced bone mineralization.

The present invention addresses the problem of indicating active-ingredient classes which can treat virus diseases caused by coronaviruses in a human or animal. Said treatment includes the acute treatment of an already existing virus disease and the prophylaxis of same. The present invention relates to a bromelain protease, bromelain, jacalin-like lectin, extract from the stem and/or the fruit of a pineapple plant, combination preparation, bromelain protease inhibitor, protein/protease mix, and glycated bromelain protein formed by exogenous non-enzymatic glycation, for use in the treatment or prophylaxis of virus infections caused by coronaviruses in a human or animal.